C.R.S. Section 44-10-209
Classes of marijuana-derived cannabinoids and compounds

  • definitions
  • privileges
  • prohibitions
  • rule-making
  • rules

(1)

Legislative declaration.
The general assembly finds and declares that:

(a)

The regulation of marijuana-derived potentially intoxicating cannabinoids and intoxicating cannabinoids, and the regulation of premises where potentially intoxicating cannabinoids and intoxicating cannabinoids are manufactured, packaged, and sold in accordance with this article 10 and rules promulgated under this article 10:

(I)

Is necessary to protect the public health; and

(II)

Will benefit consumers by ensuring that the manufacture, sale, and distribution of marijuana-derived potentially intoxicating cannabinoids and intoxicating cannabinoid products are regulated in a way to promote public health; and

(b)

The taxation of marijuana-derived potentially intoxicating cannabinoids and intoxicating cannabinoids must be addressed to ensure both compliance with Colorado voters’ intent and equitable economic treatment.

(2)

Definitions.
As used in this section, unless the context otherwise requires:

(a)

“Hemp” has the meaning set forth in section 35-61-101 (7).

(b)

Intentionally left blank —Ed.

(I)

“Semi-synthetic cannabinoid” means a substance that is created by a chemical reaction that converts one cannabinoid extracted from a cannabis plant directly into a different cannabinoid.

(II)

“Semi-synthetic cannabinoid” includes cannabinoids, such as cannabinol that was produced by the conversion of cannabidiol.

(III)

“Semi-synthetic cannabinoid” does not include cannabinoids produced via decarboxylation of naturally occurring acidic forms of cannabinoids, such as tetrahydrocannabinolic acid, into the corresponding neutral cannabinoid, such as THC, through the use of heat or light, without the use of chemical reagents or catalysts, and that results in no other chemical change.

(c)

Intentionally left blank —Ed.

(I)

“Synthetic cannabinoid” means a cannabinoid-like compound that was produced by using chemical synthesis, chemical modification, or chemical conversion, including by using in-vitro biosynthesis or other bioconversion of such a method.

(II)

“Synthetic cannabinoid” does not include:

(A)

A compound produced through the decarboxylation of naturally occurring cannabinoids from their acidic forms; or

(B)

A semi-synthetic cannabinoid.

(d)

Intentionally left blank —Ed.

(I)

“Tetrahydrocannabinol” or “THC” means the substance contained in the plant cannabis species, in the resinous extracts of the cannabis species, or a carboxylic acid of, derivative of, salt of, isomer of, or salt or acid of an isomer of these substances.

(II)

“Tetrahydrocannabinol” or “THC” includes:

(A)

Delta-10 THC and its isomers;

(B)

Delta-9 THC and its isomers;

(C)

Delta-8 THC and its isomers;

(D)

Delta-7 THC and its isomers;

(E)

Delta-6a, 10a THC and its isomers; and

(F)

Exo-tetrahydrocannabinol.

(III)

“Tetrahydrocannabinol” or “THC” may also contain:

(A)

Products of any of the compounds listed in subsections (2)(d)(II)(A) to (2)(d)(II)(F) of this section; or

(B)

Metabolites of any of the compounds listed in subsections (2)(d)(II)(A) to (2)(d)(II)(F) of this section.

(3)

Classification of marijuana-derived compounds and cannabinoids - rules.

(a)

Marijuana-derived compounds and cannabinoids are divided into three classifications:

(I)

Nonintoxicating cannabinoids;

(II)

Potentially intoxicating cannabinoids; and

(III)

Intoxicating cannabinoids.

(b)

Intentionally left blank —Ed.

(I)

Nonintoxicating cannabinoids include:

(A)

Full spectrum hemp extract that contains no more than one and three-fourths milligrams of THC per serving and contains a ratio of cannabidiol to THC of greater than or equal to fifteen to one;

(B)

Broad spectrum hemp extract;

(C)

Cannabidiol, also known as “CBD”;

(D)

Tetrahydrocannabivarin, also known as “THCV”;

(E)

Cannabichromene, also known as “CBC”;

(F)

Cannabicitran, also known as “CBT”;

(G)

Cannabicyclol, also known as “CBL”;

(H)

Cannabielsoin, also known as “CBE”;

(I)

Cannabigerol, also known as “CBG”;

(J)

Cannabidivarin, also known as “CBDV”; and

(K)

Cannabinol, also known as “CBN”.

(II)

Intentionally left blank —Ed.

(A)

Nonintoxicating cannabinoids that are derived from hemp may be used as an ingredient in a hemp product or as a finished hemp product in accordance with section 25-5-427 and the rules promulgated under part 4 of article 5 of title 25 or in accordance with this article 10 and any rules promulgated under this article 10.

(B)

A retail marijuana product containing a marijuana-derived nonintoxicating cannabinoid as an ingredient is subject to retail marijuana sales tax in accordance with section 39-28.8-202.

(c)

Intentionally left blank —Ed.

(I)

A licensee under this article 10 may manufacture, process, transfer, or sell potentially intoxicating cannabinoids that are derived from marijuana in accordance with this article 10 and the rules promulgated under this article 10.

(II)

A retail marijuana product containing a marijuana-derived potentially intoxicating cannabinoid as an ingredient is subject to retail marijuana sales tax in accordance with section 39-28.8-202.

(d)

Intentionally left blank —Ed.

(I)

Intoxicating cannabinoids include the following in an amount that exceeds the amount established by rule or, if no rule establishes the amount, in any amount:

(A)

Delta-10 THC and its isomers;

(B)

Delta-9 THC and its isomers;

(C)

Delta-8 THC and its isomers;

(D)

Delta-7 THC and its isomers;

(E)

Delta-6a, 10a THC and its isomers;

(F)

Exo-tetrahydrocannabinol;

(G)

Metabolites of THC, including 11-hydroxy-THC, 3-hydroxy-THC, or 7-hydroxy-THC;

(H)

Hydrogenated forms of THC, including hexahydrocannabinol, hexahydrocannabiphorol, and hexahydrocannabihexol;

(I)

Synthetic forms of THC, including dronabinol;

(J)

Ester forms of THC, including delta-8 THC-O-acetate, delta-9 THC-O-acetate, and hexahydrocannabinol-O-acetate;

(K)

Varin forms of THC, including delta-8 tetrahydrocannabivarin but excluding delta-9 tetrahydrocannabivarin;

(L)

Analogues of tetrahydrocannabinols with an alkyl chain of four or more carbon atoms, including tetrahydrocannabiphorols, tetrahydrocannabioctyls, tetrahydrocannabihexols, or tetrahydrocannabutols; and

(M)

Any combination of the compounds, including hexahydrocannabiphorol-O-ester, listed in this subsection (3)(d)(I).

(II)

Intentionally left blank —Ed.

(A)

A person licensed under this article 10 may use an intoxicating cannabinoid that is derived from marijuana as an ingredient in a regulated marijuana product or as a finished regulated marijuana product in accordance with this article 10 and the rules promulgated under this article 10.

(B)

A retail marijuana product containing a marijuana-derived intoxicating cannabinoid as an ingredient is subject to retail marijuana sales tax in accordance with section 39-28.8-202.

(e)

Intentionally left blank —Ed.

(I)

A person shall not manufacture, produce, sell, or offer to sell a synthetic cannabinoid or a product containing a synthetic cannabinoid unless authorized by rule. If synthetic cannabinoids are permitted by rule, the state licensing authority, in coordination with the department of public health and environment, shall promulgate rules providing standards and requirements for the manufacture and production of synthetic cannabinoids in Colorado. The rules must include a requirement that marijuana-derived products manufactured or produced in Colorado that contain a semi-synthetic or synthetic cannabinoid as an ingredient are labeled in accordance with rules promulgated pursuant to this article 10.

(II)

The state licensing authority may promulgate rules that are necessary for the fair, impartial, and comprehensive administration of this section.

(III)

A person licensed under this article 10 that produces semi-synthetic cannabinoids shall comply with the production, testing, and labeling requirements established by rule of the state licensing authority.

(f)

The state licensing authority, in coordination with the department of public health and environment, may promulgate rules to:

(I)

Classify a marijuana-derived compound or cannabinoid that is not classified in this subsection (3);

(II)

Reclassify a marijuana-derived compound or cannabinoid classified in this subsection (3) if:

(A)

The state has adopted or federal law has established a process to review and approve marijuana-derived compounds or cannabinoids;

(B)

The review and approval process described in subsection (3)(f)(II)(A) of this section evaluates the intoxicating potential of the marijuana-derived compound or cannabinoid; and

(C)

The reclassification is based on the findings of the process and evaluation described in subsections (3)(f)(II)(A) and (3)(f)(II)(B) of this section.

(g)

To reclassify a marijuana-derived compound or cannabinoid, under subsection (3)(f) of this section, the reclassification must:

(I)

Be supported by peer-reviewed research or clinical trials establishing to a reasonable degree of scientific certainty that the marijuana-derived compound or cannabinoid or the product containing a marijuana-derived compound or cannabinoid should be reclassified; or

(II)

Be based on a threat to human health, including substantial reports of intoxication or adverse health event reports.

(4)

Rules.
In addition to any powers listed in this section, the state licensing authority may promulgate rules:

(a)

Necessary to authorize or prohibit chemical modification, conversion, or synthetic derivation of cannabinoids or marijuana-derived compounds, unless otherwise permitted by this article 10 and the rules promulgated under this article 10; or

(b)

Authorizing, prohibiting, or regulating marijuana-derived ingredients in medical or retail marijuana products that are compounds other than cannabinoids.

Source: Section 44-10-209 — Classes of marijuana-derived cannabinoids and compounds - definitions - privileges - prohibitions - rule-making - rules, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-44.­pdf (accessed Oct. 20, 2023).

44‑10‑101
Short title
44‑10‑102
Legislative declaration
44‑10‑103
Definitions - rules
44‑10‑104
Applicability - medical marijuana - retail marijuana
44‑10‑105
Marijuana employee designation
44‑10‑106
Marijuana employee labor rights
44‑10‑201
State licensing authority - creation
44‑10‑202
Powers and duties of state licensing authority - stakeholder work group - rules - report - legislative declaration
44‑10‑203
State licensing authority - rules
44‑10‑204
Confidentiality
44‑10‑207
Authority to seize and destroy marijuana - public health, safety, and welfare
44‑10‑208
Feasibility report - standing committee - report - definition - repeal
44‑10‑209
Classes of marijuana-derived cannabinoids and compounds - definitions - privileges - prohibitions - rule-making - rules
44‑10‑301
Local licensing authority - applications - licenses
44‑10‑302
Local license fees - medical marijuana
44‑10‑303
Public hearing notice - posting and publication
44‑10‑304
Results of investigation - decision of authorities - medical marijuana
44‑10‑305
State licensing authority - application and issuance procedures
44‑10‑306
Denial of application
44‑10‑307
Persons prohibited as licensees - definition
44‑10‑308
Business and owner requirements - legislative declaration - definition
44‑10‑309
Business owner and financial interest disclosure requirements
44‑10‑310
Business owner and financial interest suitability requirements
44‑10‑311
Restrictions for applications for new licenses
44‑10‑312
Transfer of ownership
44‑10‑313
Licensing in general - rules
44‑10‑314
License renewal
44‑10‑315
Inactive licenses
44‑10‑316
Unlawful financial assistance
44‑10‑401
Classes of licenses
44‑10‑501
Medical marijuana store license
44‑10‑502
Medical marijuana cultivation facility license - rules - definitions
44‑10‑503
Medical marijuana products manufacturer license - rules - definition
44‑10‑504
Medical marijuana testing facility license - rules
44‑10‑505
Medical marijuana transporter license - definition
44‑10‑506
Medical marijuana business operator license
44‑10‑507
Marijuana research and development license
44‑10‑601
Retail marijuana store license - rules - definitions
44‑10‑602
Retail marijuana cultivation facility license - rules - definitions
44‑10‑603
Retail marijuana products manufacturer license - rules - definition
44‑10‑604
Retail marijuana testing facility license - rules
44‑10‑605
Retail marijuana transporter license - definition
44‑10‑606
Retail marijuana business operator license
44‑10‑607
Retail marijuana accelerator cultivator license
44‑10‑608
Retail marijuana accelerator manufacturer license
44‑10‑609
Marijuana hospitality business license
44‑10‑610
Retail marijuana hospitality and sales business license
44‑10‑611
Retail marijuana accelerator store license
44‑10‑701
Unlawful acts - exceptions
44‑10‑702
Unlawful open and public consumption
44‑10‑801
Marijuana cash fund - transfer - repeal
44‑10‑802
Fees - allocation
44‑10‑803
Fees
44‑10‑901
Suspension - revocation - fines
44‑10‑902
Disposition of unauthorized marijuana or marijuana products and related materials - rules
44‑10‑1001
Inspection procedures
44‑10‑1101
Judicial review
44‑10‑1201
Responsible vendor program - standards - designation
44‑10‑1202
Responsible vendor - designation
44‑10‑1301
Severability
44‑10‑1401
Sunset review - repeal of article
Green check means up to date. Up to date

Current through Fall 2024

§ 44-10-209’s source at colorado​.gov